Millipore Shareholders OK Merck KGaA Acquisition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore today said that its shareholders have voted in favor of the firm's acquisition by Germany's Merck KGaA.

The Billerica, Mass.-based research products firm said that shareholders representing around 79 percent of its shares voted, with 98 percent voting in favor of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.